3rd Annual Biomarkers Conference 2010
March 23 - 24, 2010(Ended)BSG Conference Centre
London, United Kingdom
London, United Kingdom
Pharmaceutical and biotech companies are looking for new ways to increase the efficiency of drug discovery process while minimising costs and time for approvals. Biomarkers are fast becoming an essential part of clinical development from discovery to approval. According to industry research, the global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7%.Venue
Address
236 City Road,
London,
United Kingdom
London,
United Kingdom
Prices *
999-1299 Pound Sterling
Organization
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Chronic lymphocytic leukemia and related disorders - Clinical
- Cochlear Implantation in Auditory Neuropathy
- Medical conferences—establishing awareness in medical fields
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Cancer Basic Research
